FCF Life Sciences partners with YAFO Capital

We are happy to announce our partnership with YAFO Capital, a China-focused life sciences specialist. Today, YAFO is part of our global network, providing access to financial and strategic life sciences investors. Similar to our access to the top 150 US investors, we can now provide a similar universe of Chinese and Asian investors for our clients’ fundraising, licensing and M&A.
As a first actionable benefit for our existing and potential European customers, we are offering the opportunity to present at the “ACCESS CHINA Partnering Day” – the largest online corporate access event between China and Western Biopharma Industry.
We cordially invite you to present your company / one of your portfolio companies at the partnering day online on May 15th, 2020. The participation through FCF Life Sciences is free-of-charge.
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand into the Chinese market. The event will help western biopharma companies to efficiently present their assets online in front of 500+ biopharma companies and healthcare VCs in China. It creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. Over 1,000 attendees are expected to present more than 20 partnering opportunities from the U.S., Europe, Japan, Korea, and China.
We are looking forward to welcome you to the partnering event. Should you have any questions, please do not hesitate to contact us.
For enquiries please contact: Dr. Mathias Schott: mathias.schott@fcf.de
To submit your pitch deck, please send to: accesschina@fcf.de